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APOE ɛ4 is Associated with Postictal Confusion in Patients with Medically Refractory 
Temporal Lobe Epilepsy 
Jessica S. Chapin, Robyn M. Busch, Damir Janigro, Michelle Dougherty, Cristiane Q. 
Tilelli, Tara T. Lineweaver, Richard I. Naugle, Ramon Diaz-Arrastia, Imad M. Najm 
Summary 
This study examined the relationship between the APOE ɛ4 allele and postictal confusion in patients with 
medically intractable temporal lobe epilepsy (TLE). Patients with at least one ɛ4 allele (n = 22) were three 
times more likely to exhibit postictal confusion (68%) than the 63 patients without ɛ4 (43%). These 
preliminary results demonstrate that APOE ɛ4 is associated with an increased risk of postictal confusion 
in patients with medically intractable TLE, suggesting possible dysfunction in neuronal recovery 
mechanisms. 
Introduction 
Postictal confusion is characterized by impaired awareness and often occurs after complex partial 
or generalized seizures. It has been defined as “temporary incoherence, inability to respond to 
contact or unfamiliarity with environment” (Epilepsy Foundation, 2007). Postictal confusion 
typically lasts less than 15 min (Bromfield et al., 2006), but occasionally persists for longer 
durations. Although postictal confusion occurs in many patients with temporal lobe epilepsy 
(TLE), and particularly those with amygdala atrophy (Guerreiro et al., 1999), its causes are 
poorly understood. 
 A primary genetic candidate related to postictal confusion is apolipoprotein E (APOE). 
Initially known for its role in cholesterol transport, research has established that APOE plays an 
important role in neuronal repair after injury (see Mahley, 1988 and Mahley et al., 2006 for 
reviews). Compared to the ɛ2 and ɛ3 alleles, ɛ4 has been associated with suboptimal clinical 
outcomes and/or poor prognoses after acute neuronal injury in both murine models (Horsburgh et 
al., 2000, Sabo et al., 2000 and Sheng et al., 1998) and humans (Alberts et al., 1995, Sorbi et al., 
1995, Tardiff et al., 1997 and Teasdale et al., 1997). 
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 Given the association between ɛ4 and neurological dysfunction, Ely et al. (2007) 
hypothesized that ɛ4 may increase the duration of delirium during critical illness. They found 
that ɛ4 was associated with increased duration of delirium in 53 mechanically ventilated patients 
with various disorders (e.g., sepsis, pneumonia) in an intensive care unit setting. Specifically, 
those with at least one ɛ4 allele had a median duration of delirium of 4 days, while those without 
an ɛ4 allele had a median duration of delirium of 2 days. These authors hypothesized that 
impaired neuronal recovery mechanisms associated with ɛ4, such as increased inflammatory 
response, may contribute to the persistence of delirium in patients with this allele. 
 Based on evidence that ɛ4 is related to impaired neuronal recovery mechanisms and that 
epileptic seizures cause neuronal injury (Houser, 1992 and Vezzani and Granata, 2005), ɛ4 may 
be associated with impaired neuronal recovery after seizures, leading to increased risk of 
postictal confusion. Thus, the purpose of this study was to determine if the APOE ɛ4 allele is 
related to greater incidence of postictal confusion in patients with medically intractable TLE. 
Methods 
The data for this retrospective study were obtained from a patient registry approved by the 
Cleveland Clinic Institutional Review Board. Two individuals were excluded due to unavailable 
postictal confusion data, resulting in a sample of 85 individuals who underwent anterior temporal 
lobectomy for the treatment of medically intractable TLE (right = 42; left = 43). A detailed 
description of participant characteristics and inclusion criteria are reported elsewhere (Busch et 
al., 2007). Briefly, patients were included in the study if they had a Full Scale IQ of 70 or higher 
and had frozen or paraffin-embedded tissue that underwent DNA analysis. See Table 1 for a 
description of demographic and seizure variables across groups. 
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 Postictal confusion was coded by two independent raters (M.D. and J.C.) based on review 
of the initial intake evaluation report and the video-EEG monitoring report. Raters were blinded 
to ɛ4 status, and interrater reliability for a subsample was acceptable (α = 0.86). Postictal 
confusion was defined by epileptologist notation in the medical record that (1) the participant or 
family reported postictal confusion on direct questioning during the initial clinical evaluation, or 
(2) the word “confusion,” regardless of duration, was used to describe the postictal period after at 
least one of the seizures during video-EEG monitoring. Duration of confusion was noted in 27 of 
the 42 patients for whom postictal confusion was reported in the medical records and ranged 
from 1 to 300 min (median = 10, interquartile range = 24). Notation of postictal dysphasia was 
not considered to reflect postictal confusion. APOE status was determined by DNA extracted 
from 20 mg of frozen or paraffin-embedded brain tissue obtained at time of surgery. For 
additional details regarding the methods used for DNA genotyping, please see Busch et al. 
(2007). 
 To compare prevalence of postictal confusion in those with and without at least one ɛ4 
allele, patients were grouped by presence or absence of an ɛ4 allele and presence or absence of 
postictal confusion. Those homozygous and heterozygous for the ɛ4 allele were combined into a 
single group due to the small number of individuals with ɛ4/4 (n = 4). Groups did not 
significantly differ on demographic or seizure variables, including side of epilepsy. Thus, side of 
epilepsy was not further considered in the following analyses. 
Results 
At least one APOE ɛ4 allele was present in 26% of the patients (n = 22; ɛ2/4 = 1, ɛ3/4 = 17, and 
ɛ4/4 = 4) and was not present in the remaining study patients (n = 63; ɛ2/3 = 13, ɛ3/3 = 50). The 
distribution of APOE genotypes was consistent with what is typically observed in the general 
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population and did not deviate from Hardy–Weinberg equilibrium. Postictal confusion was 
present in 42 patients (49%). 
 A chi-square analysis revealed that patients with an ɛ4 allele were more likely to 
experience postictal confusion than those without ɛ4 (χ2[1] = 4.18, p = .036). Specifically, of the 
22 individuals with APOE ɛ4, 15 demonstrated postictal confusion (68%), while only 27 of the 
63 without APOE ɛ4 exhibited postictal confusion (43%; see Table 2). Further, the odds ratio for 
predicting confusion based on the presence of ɛ4 was 2.86 (CI = 1.02–7.97, p = .045), suggesting 
that ɛ4 carriers were almost three times more likely to demonstrate postictal confusion than 
patients without ɛ4. 
Discussion 
The results of this study suggest that the presence of the APOE ɛ4 allele increases the risk of 
postictal confusion in patients with medically intractable TLE. Patients who possessed at least 
one ɛ4 allele were at significantly greater risk for postictal confusion than those without an ɛ4 
allele. 
 One potential reason for the association between ɛ4 and postictal confusion is that ɛ4 may 
impair neuronal recovery from injury. APOE ɛ4 has been related to poor neuronal recovery in 
murine models of stroke and closed head injury (Horsburgh et al., 2000, Sabo et al., 
2000 and Sheng et al., 1998). Further, human studies have demonstrated that ɛ4 is related to 
impaired recovery from, or poor prognosis after, acute events such as closed head injury, 
cerebral hemorrhage, ischemia, and cardiopulmonary bypass surgery (Alberts et al., 1995, Sorbi 
et al., 1995, Tardiff et al., 1997 and Teasdale et al., 1997). Recently, Ely et al. (2007) 
demonstrated that ɛ4 was associated with increased duration of delirium in mechanically 
ventilated patients in an intensive care unit. 
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 The mechanisms by which APOE affects neuronal recovery are not fully understood. One 
potential hypothesis is that APOE down-regulates the inflammatory response in an isoform-
specific manner (Grocott et al., 2001 and Lynch et al., 2003). For example, human studies have 
found that APOE ɛ4 was associated with an increase in the systemic inflammatory response in 
patients following cardiopulmonary bypass (Grocott et al., 2001) and was associated with more 
severe symptoms and/or increased prevalence of neuroinflammatory disorders such as multiple 
sclerosis (Evangelou et al., 1999, Kinnecom et al., 2007 and Schmidt et al., 2002). Specifically, 
ɛ4 has been shown to be less effective than ɛ2 and ɛ3 at suppressing glial activation in the 
context of brain inflammation (Barger and Harmon, 1997, Egensperger et al., 
1998 and Laskowitz et al., 2001). The relationship between APOE ɛ4 and inflammation, in 
combination with evidence that seizures are associated with neuronal inflammatory processes 
(Vezzani and Granata, 2005), suggests that inflammation may be a mediating factor in the 
relationship between ɛ4 and postictal confusion. 
 Additional potential mechanisms for the effect of the APOE allele on postictal confusion 
come from the Alzheimer disease literature. APOE ɛ4 has been found to result in increased Aβ 
peptide binding (Strittmatter et al., 1993), decreased cytoskeletal stability including microtubule 
breakdown and impaired neurite outgrowth (Mahley et al., 1995, Nathan et al., 
1995 and Strittmatter et al., 1994), and decreased synaptogenesis and synaptic plasticity after 
neuronal injury (Levi et al., 2003). Over time, these factors may result in decreased functional 
reserve capacity and poorer recovery from seizures in patients with epilepsy. 
 Although not investigated in the current study, seizure-aggravating variables may 
mediate the relationship between ɛ4 and postictal confusion. Studies examining the relationships 
between APOE ɛ4 and epilepsy prevalence/severity have yielded mixed results (Blümcke et al., 
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1997, Diaz-Arrastia et al., 2003, Gambardella et al., 1999, Ponomareva et al., 2007 and Yeni et 
al., 2005). Sporiš et al. (2005) found that patients with epilepsy and an ɛ4 allele were less likely 
to respond to antiepileptic medications than those without ɛ4. They surmised that this finding 
may reflect destabilization of lipid binding associated with the ɛ4 allele, leading to greater 
instability of the neuronal membrane and more frequent uncontrolled electrical discharges in 
patients. Further, postictal confusion has been related to more diffuse spiking abnormalities and 
brain atrophy (Gambardella et al., 1995). Thus, the increased neuronal membrane instability 
associated with ɛ4 may lead to increased prevalence of postictal confusion. 
 Interestingly, the ɛ4 allele was also associated with decreased memory abilities in a 
subsample of patients from the current study who had longstanding epilepsy, further highlighting 
the effect of ɛ4 on these individuals (Busch et al., 2007). It is possible that ɛ4 is associated with 
more global cognitive dysfunction compared to those without ɛ4, resulting in decreased ability to 
compensate during the postictal period. This remains to be investigated. 
 The results of the current study offer a first glance at the relationship between APOE ɛ4 
and postictal confusion, although they are limited by several factors. First, the behavioral 
manifestations of postictal confusion and postictal language disturbance may overlap, making it 
difficult to distinguish between the two. Due to the greater prevalence of postictal dysphasia in 
patients with dominant TLE, the occurrence of postictal confusion may be overestimated in this 
population. Although more patients with left TLE exhibited postictal confusion than those with 
right TLE in the current study, this difference was not significant, and the side of epilepsy did 
not moderate the relationship between APOE allele and postictal confusion. This suggests that 
confusion was distinguishable from dysphasia, and postictal language abnormalities did not 
significantly affect the current findings. A second limitation of this study is that coding of 
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confusion was based on patient/family report and observation during video-EEG monitoring. As 
this was a retrospective study, no standard and explicit behavioral criteria were used to define 
confusion in the medical record. Lack of objective behavioral criteria may have reduced 
reliability of this variable. The sample size in each cell was small after being stratified for both 
ɛ4 status and postictal confusion (n = 7–36 per cell). However, despite the reduction in statistical 
power that could result from decreased reliability and the small sample size, this study found that 
APOE ɛ4 resulted in an increased risk of postictal confusion. Finally, the relationship between 
APOE and postictal confusion requires replication in additional, broader samples, including 
populations with less severe epilepsy, to determine the generalizability and pervasiveness of this 
relationship. Future research with larger and broader epilepsy samples and more specific 
behavioral criteria for postictal confusion will be needed to further elucidate the role of APOE ɛ4 
in postictal confusion and factors that may moderate or mediate this relationship. 
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Table 1. Demographic and seizure variables across patient groups 
Variable 





−ɛ4 (n = 36) +ɛ4 (n = 7) −ɛ4 (n = 27) +ɛ4 (n = 15) 
Age 34.4 (11.7) 37.3 (13.4) 39.0 (11.2) 34.5 (9.4) 
Education 12.7 (1.8) 13.1 (1.7) 13.6 (2.3) 13.9 (3.0) 
Full Scale IQ 94.4 (13.3) 99.6 (19.6) 93.9 (10.3) 97.2 (13.8) 
Age at seizure onset 12.3 (9.9) 10.4 (8.8) 16.5 (10.4) 15.4 (9.4) 
Duration of seizures 21.4 (11.7) 27.0 (17.4) 22.4 (14.8) 19.1 (8.6) 
Sex 
 Male 15 (42%) 3 (43%) 11 (41%) 7 (47%) 
 Female 21 (58%) 4 (57%) 16 (59%) 8 (53%) 
Race 
 White 34 (94%) 7 (100%) 26 (96%) 15 (100%) 
 Black 2 (6%) 0 0 0 
 Hispanic 0 0 1 (3%) 0 
Side of epilepsy 
 Left 17 (47%) 2 (29%) 17 (63%) 7 (47%) 
 Right 19 (53%) 5 (71%) 10 (36%) 8 (53%) 
Data represent mean (S.D.) or n (%). All continuous variables with the exception of IQ are represented in years. 
−ɛ4 = participants without an ɛ4 allele; +ɛ4 = participants with at least 1 ɛ4 allele. 
Table 2.  Frequency of patients with and without an APOE ɛ4 allele who did and did not exhibit postictal confusion, 










 −ɛ4 36 27 (43% of −ɛ4) 63 
 +ɛ4 7 15 (68% of +ɛ4) 22 
 Total 43 42 85 
−ɛ4 = participants without an ɛ4 allele; +ɛ4 = participants with at least 1 ɛ4 allele. 
 
